StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Meanwhile SZLS is trading in a narrow trading zone.

<< Previous

Bullboard Posts

Next >>

Comment by MarketMoneyon Jan 13, 2022 3:52pm

197 Views

Post# 34314362

RE:RE:Meanwhile SZLS is trading in a narrow trading zone.

Pacman28 wrote:
I respect your analysis. although to get up to 15 per day over the next 24 is small potatoes. we figured out they employ 40-50 people.. all that manpower for 15 tests a day? hopefully we are doing lots of Covid tests still

My analysis is for a break even so I can judge how much test is needed to be cashflow positive. This means no more PP, in others words no more share dilution because of financial stress. I'm pretty sure when things get going it will surpass the 15 test/day.

Thanks for your input

Have a nice day

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec